4b, 5b), however notable conformational differences were observed around residues (acylated K1 Cagri , 14E Cagri , 17R Cagri and 37P Cagri ) that diverge from rAmy and pramlintide, an Amy peptide approved clinically for diabetes 6,7
Common side effects may include nausea, vomiting, diarrhea, abdominal pain, constipation, headache, dizziness, fatigue, or mild injection site reactions
Tirzepatide is administered as a subcutaneous injection
What Is the Cellular Mechanism of SPI-1005 in Inner Ear Tissue
investigation may impact future claims and product labeling discussions in the U.S
Freezing is listed as not recommended because it can damage the peptide structure, and the storage table says to keep the medication above 2 degrees Celsius